A Study of Digital Cognitive Behavioural Therapy for Insomnia in Fibromyalgia (Pain-LESS)
Fibromyalgia
About this trial
This is an interventional treatment trial for Fibromyalgia focused on measuring sleep, digital, cognitive behavioural therapy for insomnia, fibromyalgia, pain, cognition
Eligibility Criteria
Inclusion Criteria: Clinical diagnosis of fibromyalgia Concomitant insomnia, frequent waking in the night or early morning waking Self-reported difficulties with concentration or memory Reliable internet access Exclusion Criteria: Patients with a poor understanding of English. Patients with known neurological or psychiatric conditions (other than depression or anxiety) likely to independently affect the results of pain assessment, for example peripheral diabetic neuropathy in the opinion of the research team Major neuropsychiatric disorder (bipolar disorder, schizophrenia or psychotic spectrum disorders) Epilepsy Cognitive impairment, dementia or neurodegenerative disorder Recent or planned surgery Current or planned night-time shift work Sleep disorders such as sleep apnoea, restless leg syndrome, circadian rhythm disorder, or parasomnia Taking prescribed sleep medications on more than 2 nights in past 2 weeks Currently receiving other psychological therapy for insomnia Pregnant or lactating
Sites / Locations
- University of OxfordRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Sleepio (dCBT-I)
Treatment as usual
6-10 weeks of digital cognitive behavioural therapy for insomnia (Sleepio) delivered online. Participants will also receive a booklet with general advice for patients with fibromyalgia, including sleep hygiene.
Participants will receive a booklet published by Versus Arthritis designed for patients with fibromyalgia with general advice, including sleep hygiene.